Full Professor(heuristic)

Epigenetics and DNA Methylation · Molecular Biology

h-index86
i10-index386
Publications1,176
Citations30,875

Grants

37 total · 9 active

NIH #1U01DK130221-01

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Expiring Soon
Amount
$353K
Period
2021-09-23 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #5U01DK130221-04

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Expiring Soon
Amount
$420K
Period
2021-09-23 → 2026-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #3U01DK130221-04S1

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Expiring Soon
Amount
$293K
Period
2021-09-23 → 2026-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

37 total · 9 active

NIH #1U01DK130221-01

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Expiring Soon
Amount
$353K
Period
2021-09-23 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #5U01DK130221-04

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Expiring Soon
Amount
$420K
Period
2021-09-23 → 2026-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #3U01DK130221-04S1

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Expiring Soon
Amount
$293K
Period
2021-09-23 → 2026-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #5U01DK130221-03

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Expiring Soon
Amount
$623K
Period
2021-09-23 → 2026-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #5U01DK130221-02

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Expiring Soon
Amount
$574K
Period
2021-09-23 → 2026-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #5R01NS111990-08

Multi-Targeting Oligonucleotide Therapeutics for Familial and Sporadic Amyotrophic Lateral Sclerosis

Active
Amount
$666K
Period
2019-05-15 → 2029-05-31
PIs
2
Est. capacity / PI
~1 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5R01NS111990-07

Multi-Targeting Oligonucleotide Therapeutics for Familial and Sporadic Amyotrophic Lateral Sclerosis

Active
Amount
$666K
Period
2019-05-15 → 2029-05-31
PIs
2
Est. capacity / PI
~1 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #2R01NS111990-06

Multi-Targeting Oligonucleotide Therapeutics for Familial and Sporadic Amyotrophic Lateral Sclerosis

Active
Amount
$666K
Period
2019-05-15 → 2029-05-31
PIs
2
Est. capacity / PI
~1 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5U01DK130221-05

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Active
Amount
$418K
Period
2021-09-23 → 2027-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #1R01HL152322-01A1

Diffuse optical spectroscopies to assess cerebral hemodynamics in pediatric sickle cell disease

Amount
$624K
Period
2021-01-01 → 2024-12-31
PIs
2
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5R01NS111990-05

Next-generation antisense therapeutics for ALS and frontotemporal dementia

Amount
$635K
Period
2019-05-15 → 2024-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5R01NS111990-04

Next-generation antisense therapeutics for ALS and frontotemporal dementia

Amount
$635K
Period
2019-05-15 → 2024-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5R01NS111990-03

Next-generation antisense therapeutics for ALS and frontotemporal dementia

Amount
$635K
Period
2019-05-15 → 2024-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5R01NS111990-02

Next-generation antisense therapeutics for ALS and frontotemporal dementia

Amount
$635K
Period
2019-05-15 → 2024-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #1R01NS111990-01

Next-generation antisense therapeutics for ALS and frontotemporal dementia

Amount
$660K
Period
2019-05-15 → 2024-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #3U01DK130221-02S1

Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network

Amount
$189K
Period
2021-09-23 → 2023-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #5R01HL121788-05

Micro Coherence Imaging Technology for Assessing Obstructive Lung Disease in vivo

Amount
$753K
Period
2014-09-01 → 2021-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5R01HL121788-04

Micro Coherence Imaging Technology for Assessing Obstructive Lung Disease in vivo

Amount
$750K
Period
2014-09-01 → 2019-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5R01HL121788-03

Micro Coherence Imaging Technology for Assessing Obstructive Lung Disease in vivo

Amount
$747K
Period
2014-09-01 → 2019-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5R01HL121788-02

Micro Coherence Imaging Technology for Assessing Obstructive Lung Disease in vivo

Amount
$782K
Period
2014-09-01 → 2019-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #1R01HL121788-01A1

Micro Coherence Imaging Technology for Assessing Obstructive Lung Disease in vivo

Amount
$682K
Period
2014-09-01 → 2019-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5R01NS088689-04

Silencing C9or72 with rAAV Mediated RNAi

Amount
$464K
Period
2014-07-01 → 2019-04-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5R01NS088689-03

Silencing C9or72 with rAAV Mediated RNAi

Amount
$360K
Period
2014-07-01 → 2018-04-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5R01NS088689-02

Silencing C9or72 with rAAV Mediated RNAi

Amount
$360K
Period
2014-07-01 → 2018-04-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #1R01NS088689-01

Silencing C9or72 with rAAV Mediated RNAi

Amount
$377K
Period
2014-07-01 → 2018-04-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #3F32GM113454-02S1

Chemical Tools to Study and Exploit Bacterial Cell Wall Assembly

Amount
$0K
Period
2015-02-15 → 2017-02-14
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #5F32GM113454-02

Chemical Tools to Study and Exploit Bacterial Cell Wall Assembly

Amount
$56K
Period
2015-02-15 → 2017-02-14
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #1F32GM113454-01

Chemical Tools to Study and Exploit Bacterial Cell Wall Assembly

Amount
$52K
Period
2015-02-15 → 2017-02-14
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #5R01NS079836-04

High Throughput Screening for Compounds to Mitigate Toxicity of FUS/TLS & SOD1

Amount
$431K
Period
2012-07-01 → 2016-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5R01NS079836-03

High Throughput Screening for Compounds to Mitigate Toxicity of FUS/TLS & SOD1

Amount
$486K
Period
2012-07-01 → 2016-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5R01NS079836-02

High Throughput Screening for Compounds to Mitigate Toxicity of FUS/TLS & SOD1

Amount
$479K
Period
2012-07-01 → 2016-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #1R01NS079836-01

High Throughput Screening for Compounds to Mitigate Toxicity of FUS/TLS & SOD1

Amount
$539K
Period
2012-07-01 → 2016-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5P50HL084945-05

Imaging Core

Amount
$274K
Period
— → 2013-08-31
PIs
1
Est. capacity / PI
~4 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5U01NS052225-06

Development of New Therapeutics for Amyotrophic Lateral Sclerosis

Amount
$0K
Period
2007-09-01 → 2012-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #5P50NS040828-10

Dysferlin: Approaches to Domain Analysis and Gene Therapy

Amount
$333K
Period
2001-09-25 → —
PIs
1
Est. capacity / PI
~5 students

Awarded at BOSTON CHILDREN'S HOSPITAL

NIH #5P50NS040828-09

Dysferlin: Approaches to Domain Analysis and Gene Therapy

Amount
$330K
Period
2001-09-25 → —
PIs
1
Est. capacity / PI
~5 students

Awarded at BOSTON CHILDREN'S HOSPITAL

NIH #5P50HL084945-04

Imaging Core

Amount
$274K
Period
— → —
PIs
1
Est. capacity / PI
~4 students

Awarded at JOHNS HOPKINS UNIVERSITY

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 25
Open author page on OpenAlex →